ArticleBreast cancer research : BCR2018
Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693).
Aya Asano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.